These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 23916506

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cationic liposomes containing soluble Leishmania antigens (SLA) plus CpG ODNs induce protection against murine model of leishmaniasis.
    Heravi Shargh V, Jaafari MR, Khamesipour A, Jalali SA, Firouzmand H, Abbasi A, Badiee A.
    Parasitol Res; 2012 Jul; 111(1):105-14. PubMed ID: 22223037
    [Abstract] [Full Text] [Related]

  • 3. PEGylation of cationic liposomes encapsulating soluble Leishmania antigens reduces the adjuvant efficacy of liposomes in murine model.
    Naseri H, Eskandari F, Jaafari MR, Khamesipour A, Abbasi A, Badiee A.
    Parasite Immunol; 2017 Nov; 39(11):. PubMed ID: 28921566
    [Abstract] [Full Text] [Related]

  • 4. Liposomal SLA co-incorporated with PO CpG ODNs or PS CpG ODNs induce the same protection against the murine model of leishmaniasis.
    Shargh VH, Jaafari MR, Khamesipour A, Jaafari I, Jalali SA, Abbasi A, Badiee A.
    Vaccine; 2012 Jun 06; 30(26):3957-64. PubMed ID: 22465747
    [Abstract] [Full Text] [Related]

  • 5. Immunoliposomes containing Soluble Leishmania Antigens (SLA) as a novel antigen delivery system in murine model of leishmaniasis.
    Eskandari F, Talesh GA, Parooie M, Jaafari MR, Khamesipour A, Saberi Z, Abbasi A, Badiee A.
    Exp Parasitol; 2014 Nov 06; 146():78-86. PubMed ID: 25246326
    [Abstract] [Full Text] [Related]

  • 6. The role of MPL and imiquimod adjuvants in enhancement of immune response and protection in BALB/c mice immunized with soluble Leishmania antigen (SLA) encapsulated in nanoliposome.
    Emami T, Rezayat SM, Khamesipour A, Madani R, Habibi G, Hojatizade M, Jaafari MR.
    Artif Cells Nanomed Biotechnol; 2018 Nov 06; 46(sup2):324-333. PubMed ID: 29607698
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of Immune Response against Leishmaniasis in BALB/c Mice Immunized with Cationic DOTAP/DOPE/CHOL Liposomes Containing Soluble Leishmania major Antigens.
    Hojatizade M, Badiee A, Khamesipour A, Jaafari MR.
    Iran J Parasitol; 2019 Nov 06; 14(1):68-77. PubMed ID: 31123470
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Chitosan Nanoparticles Loaded with Whole and Soluble Leishmania Antigens, and Evaluation of Their Immunogenecity in a Mouse Model of Leishmaniasis.
    Hojatizade M, Soleymani M, Tafaghodi M, Badiee A, Chavoshian O, Jaafari MR.
    Iran J Immunol; 2018 Dec 06; 15(4):281-293. PubMed ID: 30593742
    [Abstract] [Full Text] [Related]

  • 13. Immunization against leishmaniasis by PLGA nanospheres loaded with an experimental autoclaved Leishmania major (ALM) and Quillaja saponins.
    Tafaghodi M, Eskandari M, Kharazizadeh M, Khamesipour A, Jaafari MR.
    Trop Biomed; 2010 Dec 06; 27(3):639-50. PubMed ID: 21399606
    [Abstract] [Full Text] [Related]

  • 14. Protection induced by Leishmania Major antigens and the imiquimod adjuvant encapsulated on liposomes in experimental cutaneous leishmaniasis.
    Mehravaran A, Nasab MR, Mirahmadi H, Sharifi I, Alijani E, Nikpoor AR, Akhtari J.
    Infect Genet Evol; 2019 Jun 06; 70():27-35. PubMed ID: 30738195
    [Abstract] [Full Text] [Related]

  • 15. Leishmania donovani serine protease encapsulated in liposome elicits protective immunity in experimental visceral leishmaniasis.
    Das P, Paik D, Naskar K, Chakraborti T.
    Microbes Infect; 2018 Jan 06; 20(1):37-47. PubMed ID: 28970116
    [Abstract] [Full Text] [Related]

  • 16. gp63 in stable cationic liposomes confers sustained vaccine immunity to susceptible BALB/c mice infected with Leishmania donovani.
    Bhowmick S, Ravindran R, Ali N.
    Infect Immun; 2008 Mar 06; 76(3):1003-15. PubMed ID: 18195029
    [Abstract] [Full Text] [Related]

  • 17. Vaccination with whole-cell killed or recombinant leishmanial protein and toll-like receptor agonists against Leishmania tropica in BALB/c mice.
    Rostamian M, Bahrami F, Niknam HM.
    PLoS One; 2018 Mar 06; 13(9):e0204491. PubMed ID: 30248142
    [Abstract] [Full Text] [Related]

  • 18. The role of liposome charge on immune response generated in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63).
    Badiee A, Jaafari MR, Khamesipour A, Samiei A, Soroush D, Kheiri MT, Barkhordari F, McMaster WR, Mahboudi F.
    Exp Parasitol; 2009 Apr 06; 121(4):362-9. PubMed ID: 19211022
    [Abstract] [Full Text] [Related]

  • 19. Leishmania major: immune response in BALB/c mice immunized with stress-inducible protein 1 encapsulated in liposomes.
    Badiee A, Jaafari MR, Khamesipour A.
    Exp Parasitol; 2007 Feb 06; 115(2):127-34. PubMed ID: 16979165
    [Abstract] [Full Text] [Related]

  • 20. IL-4 contributes to failure, and colludes with IL-10 to exacerbate Leishmania donovani infection following administration of a subcutaneous leishmanial antigen vaccine.
    Bhowmick S, Ravindran R, Ali N.
    BMC Microbiol; 2014 Jan 15; 14():8. PubMed ID: 24428931
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.